set pace anoth
strong momentum rais estim po
report adjust ep estim
consensu beat driven primarili lower expect better
expect consolid optum perform driven optuminsight optumrx
also rais guidanc confirm consensu estim
within rang would surpris exceed mark
next year rais estim po new po base
ep vs previous reiter buy rate strong set
beyond
despit grow commerci risk group membership last quarter
trend remain predict well control pharmaci inpati come
low end trend particular focu declin inpati volum
acceler invest support lt growth
expect acceler invest level advanc net promot score np
roll new commerci product expand geographi otherwis lay
foundat long term growth compani like take opportun spend
away health insur fee tailwind fund measur potenti
limit upsid near term lay groundwork sever year
averag growth trade-off view accept
fischbeck focu confirm consensu see upsid
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu potenti ep bridg headwinds/tailwind
head next year confirm consensu see upsid
estim would impli growth unh current guidanc
despit number tailwind head next year health insur fee hif
suspens strong outlook easi flu comp overal remain bullish
net dbt
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
one largest manag
organ mco serv member
us intern
diversifi payer either product line geographi
custom type compani oper
optuminsight optumhealth
buy rate price object reflect
belief health care reform
oner mani believ confirm
lift group addit due scale
divers well posit benefit
health reform initi merit
consensu like start
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu potenti ep bridg headwinds/tailwind
head next year confirm consensu see upsid
estim would impli growth unh current guidanc
despit number tailwind head next year hif suspens strong
outlook easi flu comp overal remain bullish mco broadli
confirm consensu see upsid
reiter long-term ep growth target bullish commentari
notabl compani highlight current market consensu estim
adjust ep see captur compani outlook within
typic size rang estim impli growth updat
guidanc view conserv given hif suspens strong
outlin major piec potenti earn bridg
ep line guidanc like conserv given
out-performance ytd low trend environ recent optum deal
elev flu season medic loss ratio neg affect
increment flu expens beyond typic flu season estim
headwind adjust arriv adjust
ep ex hif boost assum ep growth adjust
number would impli growth report
hif suspens boost believ hif come back
littl half initi expect headwind due lower
impact tax reform tailwind vari base upon when/if hif
delay think compani see least benefit
ep estim could see ep
repres growth y/i high end lt target rang
howev note mco typic provid conserv initi guidanc
beat/rais walk estim throughout year would surpris
see provid guidanc well rang weve laid result
would expect initi guidanc
trend remain predict well control bias slightli lower
trend vs /- previous expect pharmaci inpati come
low end trend particular focu declin inpati volum notabl
compani cite nine year declin inpati util indic
trend appar stabl focu shift price recent survey manag
care brokers/consult get sens marketplac trend ground
focu price note year price skew toward competit
environ vs less competit outlook last year howev common
respons survey remain price remain consist meanwhil
manag mention would conserv price indic
stay ration wont sacrific margin member
chart respond indic competit price
chart respond indic less competit price
meanwhil accord data websit expect pay
million rebat relat commerci busi report
floor million demonstr although
compani grown commerci risk group membership past quarter
price aggress growth note rebat consist
drag ep past four year
tabl rebat fulli insur group individu plan
premium rebat relat prior year
acceler invest support growth
expect acceler invest level advanc net promot score np
roll new commerci product expand geographi otherwis lay
foundat long term growth compani like take opportun spend
away health insur fee tailwind fund measur potenti
limit upsid near term lay groundwork sever year
averag growth trade-off certainli happi accept
includ invest model view impact manag
like conserv meanwhil estim everi invest beyond
model would hit ep impact appear manag
tabl impact invest
medicar advantag see anoth strong year
expect nice result note sell season
consist expect note long term expect industri
membership growth rang would rule someth
center medicar medicaid servic estim
meanwhil although see competit marketplac believ new entrant
requir continu improv remain confid abil sustain
margin deliv strong growth note outpac industri
growth rate four straight year compani kept benefit stabl
gener improv plan member see stabl
lower premium see access improv benefit note differenti
capabl around housecal care manag initi optum enabl
reson member physician broker deliv care cost
origin medicar market lower
sampl unh market cover membership total estim cost
senior unh plan declin y/i averag market cost declin
y/i overal appear price rel line still growth bode
well especi compani also increas total address market
meanwhil ran similar analysi unh total estim drug cost ma-pd
plan market across sampl market total estim drug cost
senior unh plan declin y/i averag market cost
declin y/i impli enhanc drug benefit better market
help support unh strong growth trajectori market
tabl total cost drug cost vs market
aso set modest growth
note nation account done well win given opportun
also larger base defend compani expect self-fund portion
nation account segment see declin enrol howev look
broader self-fund market compani perform well middl market
segment seen win improv public sector
expect modest growth profil self-fund product
estim everi increas self-fund member vs model could add
unh ep
tabl potenti upsid administr servic aso
increas aso member vs model
medicaid grow perform better rfp
medicaid exposur current sit around earn appear well
posit gain share market given scale scope offer
abil coordin care across medicare/medicaid spectrum unh medicaid
busi perform well dual long-term servic
support ltss popul despit compani lose coupl request
propos rfp compani optimist growth prospect head
grow nice higher acuiti popul
well posit high acuiti popul import go forward age
medicaid enrol expect grow per year follow medicaid
beneficiari disabl grow per year children grow per year
adult grow per year
chart medicaid enrol popul type
optum perform deal addit
optum continu outperform margin busi increas
margin y/i sequenti optumhealth growth driven care deliveri
busi optumcar serv peopl y/i across health plan
target market believ mani market still earli invest stage
expect strong growth next decad optuminsight growth driven
revenu manag outsourc solut data analyt optumrx sold
client vs state win health plan union larg employ
maintain retent note initi reaction move point sale
rebat well receiv see number self insur custom
move well management note consum receiv valu plan
move point sale rebat
meanwhil optum also recent bought two specialti pharmaci avella genoa
estim combin deal could accret
tabl estim accret avella genoa specialti pharmaci deal
conclus stori track expect strong
unh result solid across board beat tick cost trend
posit read mco continu impress
momentum virtual compani busi although appear like
spend away near term upsid support futur growth still believ
consensu estim appear conserv
addit color outlook
given solid perform compani rais guidanc gaap
ep guidanc rais midpoint expect approach
adjust ep outlook rais expect approach
impli growth year year new outlook well receiv
increas guidanc beat versu consensu net earn guidanc
rais million midpoint manag reiter long
term growth target
addit note expect cost trend slightli lower better
/- basi point previous pharmaci inpati come
low end expect rang
earn call gave initi thought outlook overal
see strong momentum head next year note current consensu
estim captur outlook within normal expect rang note
consensu repres growth new seem conserv
us given long term growth target
note see tailwind surpass headwind headwind alway
cautiou medic cost ensur price trend potenti medicar
medicaid budget risk compani make invest expand
geographi care deliveri etc tailwind strong growth optum aso
account start grow improv medicaid result hif tailwind
although believ hif headwind vs
origin due lower impact tax reform note tailwind
vari base upon when/if hif delay
relat busi expect nice result note
sell season consist expect also note long
term expect industri membership growth rang wouldnt
rule someth estim
depreci amort
invest incom
net earn attribut unitedhealth
dilut net ep
flow oper
optum earn oper
unitedhealthcar earn oper
group earn
optumhealth consum serv decemb
optuminsight revenu backlog decemb
price object base ep estim premium
histor averag justifi opinion signific growth potenti
optum health servic platform downsid risk po
enrol benefit health reform would off-set cost
industri growth target optum achiev
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
